Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Secondary Lymphoid Organs

Secondary Lymphoid Organs

Secondary organs, including lymph nodes, the spleen, and mucosa-associated lymphoid tissue (MALT), work harmoniously to protect us from disease and infection.
The spleen is a vital organ in the lymphatic system, nestled in the upper left side of the abdomen. It is composed of two primary regions: the red pulp and the white pulp, each having distinct functions. The red pulp performs a significant role in blood filtration. It efficiently purges the blood of old or damaged red blood cells and...

Primary Lymphoid Organs

Primary Lymphoid Organs

Primary lymphoid organs are pivotal in the formation, development, and maturation of lymphocytes, the white blood cells that serve as the backbone of our immune system. This crucial function underscores their fundamental role in maintaining our overall health and immunity. The two primary lymphoid organs of prime importance are the red bone marrow and the thymus.
The red bone marrow is a soft, spongy tissue nestled in the interior of long bones such as the humerus and femur. It is the site...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...

Lymphoid Cells and Tissues

Lymphoid Cells and Tissues

Lymphoid cells and tissues are integral to the immune system, which is crucial in maintaining our body's defense against harmful pathogens. They form the building blocks of lymphoid organs, which include the spleen, thymus, and lymph nodes.
Lymphoid cells consist of various types of immune system cells. These include B and T lymphocytes, which are responsible for producing antibodies and killing infected cells, respectively. Dendritic cells act as messengers between the innate and adaptive...

Lymphatic Vessels and Lymph Transport

Lymphatic Vessels and Lymph Transport

Lymphatic vessels, known as lymphatics, are crucial in transporting lymph from peripheral tissues to our venous system. This process begins with lymph entering through tiny capillaries that branch through tissues. These capillaries have unique features such as larger diameters, thinner walls, and a distinctive one-way valve system formed by overlapping endothelial cells.
This one-way system allows fluids, solutes, and even pathogens to enter but prevents their return to the intercellular spaces.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma.

Nature medicine·2022

Same author

Outcomes of patients with aggressive B-cell lymphoma after failure of anti-CD19 CAR T-cell therapy: a DESCAR-T analysis.

Blood·2022

Same author

Revised MALT-IPI: A new predictive model that identifies high-risk patients with extranodal marginal zone lymphoma.

American journal of hematology·2022

Same author

A tumor volume and performance status model to predict outcome before treatment in diffuse large B-cell lymphoma.

Blood advances·2022

Same author

The use of ICU resources in CAR-T cell recipients: a hospital-wide study.

Annals of intensive care·2022

Same author

Efficacy comparison of tisagenlecleucel vs usual care in patients with relapsed or refractory follicular lymphoma.

Blood advances·2022

Search research articles

Related Experiment Videos

Lymphoma in older patients.

Catherine Thieblemont¹, Bertrand Coiffier

¹Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Service d'hématologie clinique, Pierre Bénite, France.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

|May 10, 2007

Summary

Elderly lymphoma patients, especially those with diffuse large B-cell lymphoma, benefit from adding rituximab to the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen. This combination improves survival without increasing toxicity in older adults.

Related Experiment Videos

Area of Science:

Oncology
Geriatric Medicine
Hematology

Background:

Lymphoma disproportionately affects older adults, with over half of new diagnoses in patients over 60.
Elderly patients often have comorbidities, limiting tolerance to standard high-dose chemotherapy.
Diffuse large B-cell lymphoma is the most common type in older patients, presenting similarly to younger individuals.

Purpose of the Study:

To evaluate the efficacy and safety of adding rituximab to the cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) regimen in elderly lymphoma patients.
To assess treatment outcomes, including survival rates and toxicity, in older adults with lymphoma.

Main Methods:

Retrospective analysis of elderly lymphoma patients treated with CHOP chemotherapy.
Comparison of outcomes between patients receiving CHOP alone versus CHOP plus rituximab.
Evaluation of response rates, event-free survival, and overall survival.

Main Results:

Elderly patients treated with CHOP alone show lower response rates and shorter survival compared to younger patients.
Adding rituximab to the CHOP regimen significantly improves survival rates in older lymphoma patients.
The addition of rituximab to CHOP does not increase treatment-related toxicity in the elderly population.

Conclusions:

Rituximab plus CHOP is a superior treatment option for elderly patients with lymphoma, including those over 80, provided they do not have severe organ failure.
This combination therapy enhances survival outcomes without compromising safety in older adults.
Salvage therapy after relapse offers limited benefit for most elderly patients.